Skip to main content

US ClosedU.S. Closed

Healthcare · Biotechnology

Precigen, Inc. is an American company dedicated to the discovery and development of cutting-edge gene and cellular therapies.

52W Range

84thpctl

Volume

0.59×avg

Market Cap

2.48BUSD

P/E Ratio

-6.1TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Precigen, Inc.

PGENNASDAQ Global Select·USD·Closed

Precigen, Inc.

PGENNASDAQ·USD·Closed

$6.95

−3.34%

$6.95

−$0.24 (3.34%)

52W Range

84thpctl

Volume

0.59×avg

Mkt Cap

2.48BUSD

P/E

-6.1TTM

Div Yield

–ann

PGEN: Precigen, Inc. Stock Analysis | finqOS